The US Food and Drug Administration (USFDA) has issued a warning letter to Aurobindo Pharma for violating current good manufacturing practice norms at its Telangana-based plant....
The US Food and Drug Administration (FDA) has revised the authorisations for two monoclonal antibody therapies of Regeneron and Eli Lilly to limit their usage. The...
The U.S. Food and Drug Administration (FDA) on Wednesday classified Philips’ expanded recall of certain ventilators late last year as Class 1, or the most serious...
Israel on Wednesday broadened eligibility for a fourth dose of COVID-19 vaccine to include adults under 60 with underlying medical conditions, their caretakers, and others over...
The Saudi Ministry of Investment has signed an initial agreement with UK research-based pharmaceutical and healthcare giant GlaxoSmithKline to uplift the pharmaceuticals sector in the Kingdom....
The World Health Organization’s director-general on Monday warned that conditions remain ideal for more coronavirus variants to emerge and it’s dangerous to assume omicron is the...
It was hoped that the Omicron variant of covid may prove no more than a pin-prick for economic activity. The latest gross domestic product (GDP) growth...
The European Union’s drug regulator is set to decide whether to approve Pfizer’s COVID-19 pill at the end of this month, before doing a final review...
An influential consumer advocacy group is pressing Pfizer Inc to supply more of its new Covid-19 pill Paxlovid to developing countries this year, concerned that access...
Chile, which already boasts one of the world’s highest COVID-19 vaccination rates, has agreed to purchase 2 million vaccine doses from Moderna Inc (MRNA.O), Chilean interim...
Germany expects to receive 3.8 million doses of Novavax’s (NVAX.O) newly approved COVID-19 vaccine Nuvaxovid by March 20, the health ministry said on Tuesday, as the...
Medtronic has secured approval from the US FDA for its Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator to treat chronic pain associated with diabetic peripheral neuropathy...
An Israeli government advisory panel has recommended offering a fourth COVID-19 vaccine dose to all adults, on condition that at least five months have passed since...
The FDA has issued a complete response letter declining to approve a new drug application for gefapixant to treat adults with refractory and unexplained chronic cough,...
Merck & Co’s antiviral pill will be evaluated in a large British trial as a possible treatment for patients hospitalised with Covid-19, amid the worldwide spread...
Copyright © 2024 Medical Buyer